Randomisation? [Study Per­for­mance]

posted by khaoula – Algeria, 2014-06-11 02:17 (4043 d 05:07 ago) – Posting: # 13056
Views: 19,126

Hi ElMaestro & Helmut
I think that it's important to have randomisation of subject 15 (I dont now the basis of a software (kinetica) and how tu use it), I havnt randomisation because they dont give me it, they asked me to try to understand where is the error, so when I search I found that oeprazole is a HVDP and I try to understand what FDA and EMA do, I concluded that our design is't appropriate (must have replicate design), but with Phoenix/WinNonlin CV=23.37%, so the problem of our study is number of subject, with hightest number we can conclude to biequivalence (the test drug is really bioequivalent of réference, this study was done to learn how to do biequivalennce study)


I calculated CV with error = 0.0471261 and I had CV% = 100√(ℯ0.0471261 – 1) = 21.97% but I thought that I was wrong

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,676 registered users;
31 visitors (0 registered, 31 guests [including 18 identified bots]).
Forum time: 07:24 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5